Piramal Imaging GmbH, Berlin, Germany
Departments of Medicine and Molecular Imaging, University of Melbourne, Austin Health, Melbourne, Victoria, Australia; and.
J Nucl Med. 2017 Aug;58(8):1300-1306. doi: 10.2967/jnumed.116.187351. Epub 2017 Feb 9.
Accurate measurement of changes in amyloid-β (Aβ) deposition over time is important in longitudinal studies, particularly in anti-Aβ therapeutic trials. To achieve this, the optimal reference region (RR) must be selected to reduce variance of Aβ PET measurements, allowing early detection of treatment efficacy. The aim of this study was to determine the RR that allows earlier detection of subtle Aβ changes using F-florbetaben PET. Forty-five patients with mild cognitive impairment (mean age ± SD, 72.69 ± 6.54 y; 29 men/16 women) who underwent up to 3 F-florbetaben scans were included. Baseline scans were visually classified as high (Aβ+) or low (Aβ-) amyloid. Six cortical regions were quantified using a standardized region-of-interest atlas applied to the spatially normalized gray matter image obtained from segmentation of the baseline T1-weighted volumetric MRI. Four RRs (cerebellar gray matter [CGM], whole cerebellum [WCER], pons, and subcortical white matter [SWM]) were studied. The SUV ratio (SUVR) for each RR was calculated by dividing cortex activity by RR activity, with a composite SUVR averaged over 6 cortical regions. SUVR increase from baseline to 1 and 2 y, and percentage Aβ deposition per year, were assessed across Aβ+ and Aβ- groups. SUVs for any RR were not significantly different over time. Percentage Aβ accumulation per year derived from composite SUVR was 0.10 ± 1.72 (Aβ-) and 1.36 ± 1.98 (Aβ+) ( = 0.02) for CGM and 0.13 ± 1.47 and 1.32 ± 1.75 ( = 0.01), respectively, for WCER. Compared with baseline, the composite SUVR increase in Aβ+ scans was significantly larger than in Aβ- scans at 1 y ( = 0.04 [CGM]; = 0.03 [WCER]) and 2 y ( = 0.02 [CGM]; = 0.01 [WCER]) using these 2 RRs. Significant SUVR changes using the pons as the RR were detected only at 2 y ( = 0.46 [1 y], = 0.001 [2 y]). SUVR using the SWM as the RR showed no significant differences at either follow-up ( = 0.39 [1 y], = 0.09 [2 y]). RR selection influences reliable early measurement of Aβ changes over time. Compared with SWM and pons, which do not fulfil the RR requirements and have limited sensitivity to detect Aβ changes, cerebellar RRs are recommended for F-florbetaben PET because they allow earlier detection of Aβ accumulation.
准确测量淀粉样蛋白-β(Aβ)随时间的沉积变化在纵向研究中很重要,特别是在抗 Aβ 治疗试验中。为了实现这一目标,必须选择最佳的参考区域(RR),以减少 Aβ PET 测量的方差,从而更早地发现治疗效果。本研究旨在确定使用 F-氟比他滨 PET 更早检测到细微 Aβ 变化的 RR。 45 名轻度认知障碍患者(平均年龄 ± SD,72.69 ± 6.54 岁;29 名男性/16 名女性)接受了多达 3 次 F-氟比他滨扫描。基线扫描通过视觉分类为高(Aβ+)或低(Aβ-)淀粉样蛋白。使用标准化的感兴趣区图谱对基线 T1 加权容积 MRI 获得的空间归一化灰质图像进行量化,共量化了 6 个皮质区域。研究了 4 个 RR(小脑灰质[CGM]、全小脑[WCER]、脑桥和皮质下白质[SWM])。通过将皮质活性除以 RR 活性来计算每个 RR 的 SUV 比(SUVR),并平均来自 6 个皮质区域的复合 SUVR。评估 Aβ+和 Aβ-组中从基线到 1 年和 2 年的 SUVR 增加以及每年 Aβ 沉积百分比。任何 RR 的 SUV 在整个研究期间均无明显差异。来自复合 SUVR 的每年 Aβ 积累百分比分别为 0.10 ± 1.72(Aβ-)和 1.36 ± 1.98(Aβ+)(= 0.02)对于 CGM 和 0.13 ± 1.47 和 1.32 ± 1.75(= 0.01)对于 WCER。与基线相比,在使用这 2 个 RR 时,Aβ+扫描的复合 SUVR 增加在 1 年(= 0.04 [CGM];= 0.03 [WCER])和 2 年(= 0.02 [CGM];= 0.01 [WCER])时明显更大。仅在 2 年时使用脑桥作为 RR 才能检测到明显的 SUVR 变化(= 0.46 [1 年],= 0.001 [2 年])。使用 SWM 作为 RR 的 SUVR 未在任何随访中显示出显著差异(= 0.39 [1 年],= 0.09 [2 年])。 RR 选择会影响随时间可靠地早期测量 Aβ 变化。与不满足 RR 要求且对检测 Aβ 变化的敏感性有限的 SWM 和脑桥相比,推荐使用小脑 RR 进行 F-氟比他滨 PET,因为它们可以更早地检测到 Aβ 积累。